About
Board
News
Sign Up
Contact
Visit
Home
(current)
Diseases
Genitourinary
Lung
Head and Neck
Breast
Gynecological
Skin
View all Diseases
Topics
Treatment
Early Diagnosis
Nursing
Pharmacy
Supportive Care
Policy
View all Topics
Conferences
GU Cancers
2019
BTOG
2019
UKONS
2018
NCRI
2018
ESMO
2018
EONS
2018
View all Conferences
Features
Podcasts
About
Board
News
Sign Up
Contact
ELCC 2017
1:33
Exciting current topics in lung cancer
Solange Peters
0:47
Why is European Lung Cancer Conference so important?
Solange Peters
2:43
Increasing patient access to the latest treatments
Solange Peters
1:46
Challenges and opportunities for patients with advanced NSCLC
Solange Peters
2:29
The open questions surrounding immunotherapy and targeted therapy in lung cancer
Solange Peters
1:10
The BIRCH trial data discussed by Dr Peters
Solange Peters
1:29
The LUME-BioNIS study and its aims
Keith Kerr
2:04
Biomarker testing in NSCLC
Keith Kerr
0:51
Current treatment landscape for neuroendocrine tumors
Keith Kerr
1:48
Evolving guidelines for molecular testing in lung cancer
Fred Hirsch
1:13
Phase II study of Durvalumab for patients with NSCLC
David Gandara
2:07
Increasing treatment options for NSCLC
David Gandara
2:09
Benefits of targeted therapeutics in Lung Cancer
David Carbone
1:15
Molecular tools for lung cancer therapies
Charles Swanton
1:52
ESMO guidelines for thymic cancer management
Nicolas Girard
1:00
The genetic landscape of lung cancer
Martin Reck
1
2
Next